Technology Report

Aptiv Solutions Executive Discusses the State of Mobile Health Technology Regulatory

June 23, 2013 OneMedPlace Team 0

OneMedRadio spoke with Cynthia Nolte, Director, Medical Device Regulatory Services for Aptiv Solutions, about the state of mobile health/health information technology regulatory, clinical trial design for mobile health technology, and what we can expect from future guidelines. The conclusions about regulating a rapidly evolving space — and the case studies that have pioneered this process — are intriguing, and indeed promising.

Okairos: Okay After All

June 5, 2013 OneMedPlace Team 0

On May 29th, 2013, GlaxoSmithKline (GSK) announced the acquisition of Okairos in an all-cash deal worth $325 million US. The Okairos acquisition helps complement the pharma giant’s existing vaccine technology and expertise and will enable GSK to continue its work developing the next generation of vaccines.

No Image

OneMedForumNY 2013, June 26-27

May 17, 2013 OneMedPlace Team 0

NEW YORK, October 3, 2012 – OneMedPlace has announced programming themes for its 6th Annual OneMedForum, taking place January 7-9th, 2013, at the Sir Francis Drake Hotel in San Francisco.

MAPPING THE B.R.A.I.N.

May 17, 2013 OneMedPlace Team 0

On April 2nd, 2013, U.S. President Barack Obama unveiled the “BRAIN” Initiative, which is short for Brain Research through Advancing Innovative Neurotechnologies. The BRAIN Initiative may be known as the spiritual successor to the Human Genome Project, not only for its desire to understand a mysterious place known to medical science, but for taking its cues from the initial success of the HGP.

No Image

White Paper Explores the Amarantus Bioscience Alzheimer’s Disease Diagnostic

April 25, 2013 OneMedPlace Team 0

Amarantus Bioscience has posted a White Paper exploring the company’s LymPro Alzheimer’s Disease diagnostic, prepared by a member of the company’s Board of Advisors. The Paper discusses the increasing prevalence of Alzheimer’s disease, the clinical and economic advantages of early detection, and why the LymPro Test is poised to potentially become the market leading diagnostic product in the Alzheimer’s space.

Caprion’s Proteomic Biomarkers — Diverse Clientele Leads to In-House Pipeline

April 16, 2013 OneMedPlace Team 0

Montreal-based Caprion has established itself as a leader in the proteomic biomarker discovery field, using its proteomics discovery platform CellCarta® to develop pharmacodynamic biomarkers, disease markers and predictive biomarkers. OneMedRadio spoke with Caprion President and CEO Martin Leblanc about industry trends concerning increased risk factors, securing intellectual property and developing an in vitro diagnostics platform.